Skip Navigation


European Heart Journal Advance Access originally published online on February 16, 2005
European Heart Journal 2005 26(7):740-741; doi:10.1093/eurheartj/ehi158
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/7/740-a    most recent
ehi158v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Angiolillo, D. J.
Right arrow Articles by Macaya, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Angiolillo, D. J.
Right arrow Articles by Macaya, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

 

Raising the loading dose of clopidogrel: aiming at the proper target?: reply

Dominick J. Angiolillo

Division of Cardiology, University of Florida, Shands Jacksonville, 655 West 8th Street, Jacksonville, FL 32209, USA, Tel: +1 904 2443933, Fax: +1 904 2443102, E-mail address: dominick.angiolillo@jax.ufl.edu

Antonio Fernandez-Ortiz

Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain

Esther Bernardo

Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain

Celia Ramírez

Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain

Carlos Macaya

Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain

The first 10% of the full text of this article appears below.

We acknowledge the interest of Komocsi et al. in our manuscript.1 In their letter, the rationale for the use of a high clopidogrel loading dose (LD) regimen in all patients undergoing coronary intervention is questioned. The reasons leading to such perplexity are based on the authors' perception . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?